Skip to content
OpenCapital
Get started

CONMED CNMD Dividends, Common Stock, Cash

Dividends, Common Stock, Cash at other companies

Medtronic logo
MedtronicMDT
——

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.04B-35.6%
Enterprise value$1.87B-24.5%
P/E19×+5.4×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:DividendsCommonStockCash.

The official record: CONMED’s 10-K, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's dividends, common stock, cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's dividends, common stock, cash?
CONMED (CNMD) reported dividends, common stock, cash of $0 in Q4 2025.
How has CONMED's dividends, common stock, cash changed year-over-year?
CONMED's dividends, common stock, cash decreased by 100.0% year-over-year, from $6.18M to $0.
What is the long-term trend for CONMED's dividends, common stock, cash?
Over 4 years (2021 to 2025), CONMED's dividends, common stock, cash has grown at a -5.6% compound annual growth rate (CAGR), from $23.35M to $18.57M.
What does dividends, common stock, cash mean?
Represents the total actual cash outflow paid to common shareholders as dividends during the reporting period. It reflects the company's ability to generate sufficient liquidity to support its dividend distribution strategy.